Press release
Chronic Kidney Disease Market worth $199.64 billion by 2030, growing at a CAGR of 6.50% - Exclusive Report by 360iResearch
Chronic Kidney Disease Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/chronic-kidney-disease
Chronic Kidney Disease (CKD) involves a gradual decline in kidney function, impairing the organs' ability to filter waste and excess fluids from the blood. The disease affects various stages from mild impairment to severe conditions requiring dialysis or transplantation. Key diagnostic criteria comprise a sustained reduction in glomerular filtration rate (GFR) and the presence of markers such as albuminuria. The necessity for effective CKD management is underscored by increasing global prevalence due to rising incidences of diabetes and hypertension, necessitating early diagnosis and intervention to mitigate progression and reduce mortality and healthcare costs. Applications include diagnostic tools such as biomarkers and imaging technologies, treatment modalities like pharmacological agents (ACE inhibitors, ARBs), lifestyle interventions, dialysis, transplantation, and digital health solutions encompassing apps and wearables for monitoring vital parameters. End-use sectors span hospitals, clinics, dialysis centers, research institutes, home care settings, and pharmaceutical companies. Market growth is driven by factors such as technological advances, rising prevalence, and government initiatives, including policies supporting CKD management. However, economic barriers, non-adherence to treatment, lack of awareness, stringent regulatory requirements, and technological disparities present substantial challenges. Opportunities lie in telehealth services for accessible monitoring, personalized medicine through genetic research, and artificial intelligence for predictive analytics. Recommendations include investing in AI-based predictive tools, expanding telehealth, developing personalized treatment approaches, and enhancing public awareness campaigns for early screening. Areas ripe for innovation encompass regenerative medicine, portable dialysis machines, and biomarker research. The competitive landscape is characterized by significant activity among pharmaceutical companies, diagnostic labs, and technology firms, with trends leaning towards patient-centric models, value-based care, and expansion into emerging markets, anticipating surging demand and various growth potentials despite existing challenges.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/chronic-kidney-disease
Market Segmentation & Coverage:
This research report categorizes the Chronic Kidney Disease Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Type, market is studied across Diagnosis and Treatment. The Diagnosis is further studied across Blood Tests, Imaging Tests, Kidney Biopsy, and Urine Tests. The Treatment is further studied across Dialysis, Kidney Transplant, and Medication. The Medication is further studied across ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Diuretics, Erythropoietin Stimulants, Finerenone, Glucagon-like Peptide-1 Receptor Agonists, Insulin, Metformin, Potassium Binders, Sodium-glucose Cotransporter-2 Inhibitors, and Statins.
Based on Indication, market is studied across Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis, Hypertensive Nephropathy, Obstructive Nephropathy, and Polycystic Kidney Disease.
Based on End-User, market is studied across Ambulatory Surgery Centers, Diagnostic Centers & Laboratories, Hospitals & Clinics, and Speciality Treatment Centers.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Chronic Kidney Disease Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Apotex Inc., Asahi Kasei Corporation, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Centessa Pharmaceuticals Limited, DaVita Inc., Dialife SA, Dr. Reddys Laboratories Ltd., Evoqua Water Technologies LLC, Fresenius Medical Care AG, Galapagos NV, Hemoclean Co. Ltd., JMS Co., Ltd., Johnson & Johnson Services, Inc., Medtronic PLC, Merck & Co., Inc., Nikkiso Co., Ltd., Nipro Corporation, Novartis AG, NxStage Medical Inc., Otsuka Pharmaceutical Co., Ltd., Reata Pharmaceuticals Inc., Rockwell Medical Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Toray Medical Co., Ltd., Trivitron Healthcare, and XORTX Therapeutics Inc..
Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Chronic Kidney Disease Market
We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Chronic Kidney Disease Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Chronic Kidney Disease Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.
Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/chronic-kidney-disease
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Chronic Kidney Disease Market, by Type
7. Chronic Kidney Disease Market, by Indication
8. Chronic Kidney Disease Market, by End-User
9. Americas Chronic Kidney Disease Market
10. Asia-Pacific Chronic Kidney Disease Market
11. Europe, Middle East & Africa Chronic Kidney Disease Market
12. Competitive Landscape
13. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/chronic-kidney-disease
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Market worth $199.64 billion by 2030, growing at a CAGR of 6.50% - Exclusive Report by 360iResearch here
News-ID: 3611997 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Kidney
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney …
For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.
“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research…
Kidney Cancer Drugs Market: Rising Incidence of Kidney Cancer Expected to Boost …
With only a handful of large vendors accounting collectively for a large share, the vendor landscape of the global market for kidney cancer drugs can be viewed as largely consolidated and tough to crack for new vendors, observes Transparency Market Research in a recent report. The level of competition among leading players is also quite stiff.
Among the leading players, Pfizer, Inc. accounted for the maximum share in the overall market…
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA
Major scientific sessions:
Kidney Fluid, Electrolytes, Acid-Base Disorders
Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders
Chronic Kidney Disease (CKD) Kidney and Bladder stones
Dialysis and Renal Care Urology/Urinary Tract Infections
Kidney Transplantation Geriatric-Genetic Kidney…
